LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 80.48 | 771.67 | 1158 | 11685 | 0.0991 | 0.1091 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 80.48 | 771.67 | 1855 | 11685 | 0.1588 | 0.2507 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 82.69 | 771.67 | 1158 | 11974 | 0.0967 | 0.1081 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 82.69 | 771.67 | 1849 | 11974 | 0.1544 | 0.2472 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 84.92 | 771.67 | 1140 | 12266 | 0.0929 | 0.1027 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 84.92 | 771.67 | 1958 | 12266 | 0.1596 | 0.2628 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 87.14 | 771.67 | 1145 | 12592 | 0.0909 | 0.1029 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 87.14 | 771.67 | 2084 | 12592 | 0.1655 | 0.2797 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 2.49 | 771.67 | 869 | 867 | 1.0014 | 1.0171 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 2.49 | 771.67 | 852 | 867 | 0.9819 | 0.7949 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 4.71 | 771.67 | 943 | 956 | 0.9860 | 0.9111 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 4.71 | 771.67 | 905 | 956 | 0.9463 | 0.6733 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 6.94 | 771.67 | 995 | 1045 | 0.9520 | 0.7875 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 6.94 | 771.67 | 926 | 1045 | 0.8860 | 0.5168 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 9.16 | 771.67 | 1028 | 1138 | 0.9029 | 0.6673 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 9.16 | 771.67 | 978 | 1138 | 0.8590 | 0.5255 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 11.56 | 771.67 | 1068 | 1280 | 0.8340 | 0.5600 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 11.56 | 771.67 | 1027 | 1280 | 0.8020 | 0.4787 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 13.78 | 771.67 | 1125 | 1459 | 0.7707 | 0.5067 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 13.78 | 771.67 | 1030 | 1459 | 0.7056 | 0.3689 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 16.00 | 771.67 | 1110 | 1585 | 0.7001 | 0.4190 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 16.00 | 771.67 | 1095 | 1585 | 0.6906 | 0.4005 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 18.22 | 771.67 | 1144 | 1741 | 0.6570 | 0.3984 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 18.22 | 771.67 | 1125 | 1741 | 0.6460 | 0.3786 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 20.44 | 771.67 | 1165 | 1910 | 0.6097 | 0.3701 | MN20160304_L01 | E14 |